Last $0.86 USD
Change Today -0.0267 / -3.02%
Volume 130.7K
HNSN On Other Exchanges
As of 8:10 PM 11/25/14 All times are local (Market data is delayed by at least 15 minutes).

hansen medical inc (HNSN) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/11/14 - $2.89
52 Week Low
11/11/14 - $0.60
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HANSEN MEDICAL INC (HNSN)

Related News

No related news articles were found.

hansen medical inc (HNSN) Related Businessweek News

No Related Businessweek News Found

hansen medical inc (HNSN) Details

Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies. The company offers Sensei Robotic Catheter Systems and Artisan Control Catheters for the manipulation, positioning, and control of mapping catheters during electrophysiology procedures; and Magellan Robotic System, a peripheral vascular interventional platform, which is used in combination with the Magellan Robotic Catheter for vessel navigation, catheter stability during the manual delivery and placement of therapeutic devices, reduced procedural radiation exposure and fatigue, and precise robotic control of distal catheter tips. The company also provides Lynx catheter, an irrigated ablation catheter; and CoHesion 3D Visualization Module, a software interface, which provides physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. It sells its products through direct sales force and distributors in the United States, European Union, and internationally. The company has agreements with St. Jude Medical, Inc. to integrate its Sensei system with St. Jude’s Ensite system, as well as to co-market the integrated product; and with Philips Medical Systems Nederland B.V. to co-develop integrated products. Hansen Medical, Inc. was founded in 2002 and is headquartered in Mountain View, California.

171 Employees
Last Reported Date: 03/13/14
Founded in 2002

hansen medical inc (HNSN) Top Compensated Officers

Chief Operating Officer
Total Annual Compensation: $275.0K
Vice President of Marketing & Business Develo...
Total Annual Compensation: $241.5K
Senior Vice President of Global Sales
Total Annual Compensation: $230.0K
Compensation as of Fiscal Year 2013.

hansen medical inc (HNSN) Key Developments

Hansen Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Hansen Medical, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported total revenues of USD 3.877 million compared to USD 5.068 million a year ago. Loss from operations was USD 11.362 million compared to USD 10.190 million a year ago. Loss before income taxes were USD 15.589 million compared to USD 13.161 million a year ago. Net loss was USD 15.594 million compared to USD 13.201 million a year ago. Basic and diluted net loss per share were USD 0.13 compared to USD 0.16 a year ago. For the nine months, the company reported total revenues of USD 14.463 million compared to USD 11.362 million a year ago. Loss from operations was USD 35.593 million compared to USD 38.250 million a year ago. Loss before income taxes were USD 42.291 million compared to USD 43.741 million a year ago. Net loss was USD 42.329 million compared to USD 43.834 million a year ago. Basic and diluted net loss per share were USD 0.38 compared to USD 0.60 a year ago.

Hansen Medical, Inc. to Report Q3, 2014 Results on Nov 06, 2014

Hansen Medical, Inc. announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Nov 06, 2014

Hansen Medical, Inc. Announces Global Launch of the Sensei X2(R) Robotic System

Hansen Medical, Inc. announced the Sensei X2 Robotic System is commercially available in the U.S. and European Union. Sensei X2 is a technological leap forward; featuring faster processing speeds, enhanced image integration, and a lower profile design. Launch of Sensei X2 is a key milestone as Hansen continues to deliver on its pipeline of innovative robotic platforms for electrophysiology procedures. The Sensei X2 is the third generation Sensei system. The technology has been used in over 14,000 procedures. Sensei has also been the subject of 26 clinical studies, with data collected from more than 2,700 patients. Evidence confirms low complication rates, high average contact force, catheter stability, and reduced fluoroscopy time when compared with manual procedures. The Sensei X2 Robotic System is an advanced technology used during electrophysiology procedures to remotely navigate a robotic catheter in the heart atria. Sensei technology offers catheter stability, accuracy, and access to hard-to-reach areas of the atria. Sensei's remote workstation integrates multiple imaging sources used by the physician during electrophysiology procedures.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HNSN:US $0.86 USD -0.0267

HNSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $18.54 USD +0.13
Corindus Vascular Robotics Inc $4.15 USD +0.05
LeMaitre Vascular Inc $7.27 USD +0.14
Stereotaxis Inc $1.68 USD -0.119
Spectranetics Corp/The $32.00 USD -0.29
View Industry Companies

Industry Analysis


Industry Average

Valuation HNSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.3x
Price/Book 6.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANSEN MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at